share_log

新銳醫藥：代表委任表格

NEW RAY MEDIC: FORM OF PROXY

Hong Kong Stock Exchange ·  Apr 24 08:40
Summary by Moomoo AI
新銳醫藥國際控股有限公司（「新锐医药」）將於2024年6月18日上午九時在香港中環德輔道中19號環球大廈12樓舉行股東週年大會。會議將審議包括批准截至2023年12月31日止年度的經審核綜合財務報表、董事會報告及核數師報告，以及重選王秋勤女士、褚雪平先生和梁志堅先生為董事。此外，大會將討論續聘大華馬施雲會計師事務所為核數師並授權董事會釐定酬金，授予董事配發、發行或處置公司股份的一般授權，以及購回公司股份的授權。股東將通過代表委任表格委任代表出席大會並投票。
新銳醫藥國際控股有限公司（「新锐医药」）將於2024年6月18日上午九時在香港中環德輔道中19號環球大廈12樓舉行股東週年大會。會議將審議包括批准截至2023年12月31日止年度的經審核綜合財務報表、董事會報告及核數師報告，以及重選王秋勤女士、褚雪平先生和梁志堅先生為董事。此外，大會將討論續聘大華馬施雲會計師事務所為核數師並授權董事會釐定酬金，授予董事配發、發行或處置公司股份的一般授權，以及購回公司股份的授權。股東將通過代表委任表格委任代表出席大會並投票。
NEW SHARP PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (“NEW SHARP PHARMACEUTICALS”) WILL BE HELD ON 18 JUNE 2024 AT 9:00 A.M. ON 12TH FLOOR OF GLOBAL BUILDING, 19 DES VOE ROAD CENTRAL, HONG KONG. The meeting will include the approval of the Audited Consolidated Financial Statements for the year ended December 31, 2023, the Board's Report and the Auditor's Report, and the re-election of Ms. Wang Qiu Qin, Mr. Sui Ping and Mr. Leung Chi Kin as directors. IN ADDITION, THE GENERAL MEETING WILL DISCUSS THE RENEWAL OF MAASHIWAN ACCOUNTING FIRM AS AUDITOR AND AUTHORIZING THE BOARD OF DIRECTORS TO DETERMINE REMUNERATION, GRANT GENERAL MANDATES TO DISTRIBUTE, ISSUE OR DISPOSE OF COMPANY SHARES, AND AUTHORIZATION TO REPURCHASE COMPANY SHARES. Shareholders will appoint representatives to attend and vote at the General Meeting by proxy form.
NEW SHARP PHARMACEUTICALS INTERNATIONAL HOLDINGS LIMITED (“NEW SHARP PHARMACEUTICALS”) WILL BE HELD ON 18 JUNE 2024 AT 9:00 A.M. ON 12TH FLOOR OF GLOBAL BUILDING, 19 DES VOE ROAD CENTRAL, HONG KONG. The meeting will include the approval of the Audited Consolidated Financial Statements for the year ended December 31, 2023, the Board's Report and the Auditor's Report, and the re-election of Ms. Wang Qiu Qin, Mr. Sui Ping and Mr. Leung Chi Kin as directors. IN ADDITION, THE GENERAL MEETING WILL DISCUSS THE RENEWAL OF MAASHIWAN ACCOUNTING FIRM AS AUDITOR AND AUTHORIZING THE BOARD OF DIRECTORS TO DETERMINE REMUNERATION, GRANT GENERAL MANDATES TO DISTRIBUTE, ISSUE OR DISPOSE OF COMPANY SHARES, AND AUTHORIZATION TO REPURCHASE COMPANY SHARES. Shareholders will appoint representatives to attend and vote at the General Meeting by proxy form.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more